Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli(Vita-Salute San Raffaele University), Barbara Camisa, Giulia Barbiera(The San Raffaele Telethon Institute for Gene Therapy), Laura Falcone, Ayurzana Purevdorj, Marco Genua(The San Raffaele Telethon Institute for Gene Therapy), Francesca Sanvito(San Raffaele University of Rome), Maurilio Ponzoni(San Raffaele University of Rome), Claudio Doglioni(San Raffaele University of Rome), Patrizia Cristofori(The San Raffaele Telethon Institute for Gene Therapy), Catia Traversari(MolMed (Italy)), Claudio Bordignon(Vita-Salute San Raffaele University), Fabio Ciceri(Vita-Salute San Raffaele University), Renato Ostuni(The San Raffaele Telethon Institute for Gene Therapy), Chiara Bonini(Vita-Salute San Raffaele University), Monica Casucci, Attilio Bondanza(Vita-Salute San Raffaele University)
Cited by 1,367
Abstract
Related Papers
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia